Eli Lilly and Comp. (LLY) stock forecast for 2021. Forecast tables and graphs.

Eli Lilly and Comp. (LLY) stock forecast for 2021

The forecast has been updated: June 17, 2021 8:38


Eli Lilly and Comp. stock price online today

Analyst Target Price

216.36

Dividend Date

10.06.2021

Ex Dividend Date

13.05.2021

Last Split Factor

2:1

Last Split Date

16.10.1997

Should you buy or sell Eli Lilly and Comp. stock stock today? What is the projected target price level for 2021? How much will it cost in 2021? Eli Lilly and Comp. stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2021.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $216.36 target price for Eli Lilly and Comp. stock stock.

Today 200 Day Moving Average is the support level (189.682 $).

50 Day Moving Average is the resistance level (200.652 $).




LLY Forecast for 2021

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jul 247.74 231.31 265.13 12.75 %
Aug 261.26 235.11 285.04 17.52 %
Sep 268.74 246.73 289.70 14.83 %
Oct 243.58 230.92 264.80 12.80 %
Nov 215.08 199.15 226.55 12.10 %
Dec 209.21 189.63 230.43 17.70 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Eli Lilly and Comp. stock.


Eli Lilly and Comp. overview

Eli Lilly and Comp. Address

Lilly Corporate Center, Indianapolis, IN, United States, 46285

Market Capitalization

213 231 353 856 $

EBITDA

8 494 000 128

PE Ratio

33.2847

PEG Ratio

2.3782

Dividend Per Share

3.07

Dividend Yield

0.0137

EPS

6.68

Quarterly Earnings Growth YOY

-0.069

Quarterly Revenue Growth YOY

0.161

Trailing PE

33.2847

Forward PE

28.6533

EV To Revenue

8.9486

EV To EBITDA

25.9695

52 Week High

235.847

52 Week Low

127.4597

50 Day Moving Average

200.652

200 Day Moving Average

189.682

Shares Outstanding

959025024

Shares Float

857101913

Shares Short Prior Month

8909984

Short Ratio

2.51

Percent Insiders

0.153

Percent Institutions

83.678

Eli Lilly and Comp. stock forecast for this year


Eli Lilly and Comp. stock forecast for Jul 2021.
Estimated Average Forecasted Eli Lilly and Comp. Price: 247.74. Positive monthly dynamics of the instrument is expected with 12.755% volatility is expected.

Pessimistic forecast: 231.31

Optimistic: 265.13


Eli Lilly and Comp. stock forecast for Aug 2021.
Estimated Average Forecasted Eli Lilly and Comp. Price: 261.26. Positive monthly dynamics of the instrument is expected with 17.516% volatility is expected.

Pessimistic forecast: 235.11

Optimistic: 285.04


Eli Lilly and Comp. stock forecast for Sep 2021.
Estimated Average Forecasted Eli Lilly and Comp. Price: 268.74. Positive monthly dynamics of the instrument is expected with 14.833% volatility is expected.

Pessimistic forecast: 246.73

Optimistic: 289.70


Eli Lilly and Comp. stock forecast for Oct 2021.
Estimated Average Forecasted Eli Lilly and Comp. Price: 243.58. Negative monthly dynamics of the instrument is expected with 12.795% volatility is expected.

Pessimistic forecast: 230.92

Optimistic: 264.80


Eli Lilly and Comp. stock forecast for Nov 2021.
Estimated Average Forecasted Eli Lilly and Comp. Price: 215.08. Negative monthly dynamics of the instrument is expected with 12.096% volatility is expected.

Pessimistic forecast: 199.15

Optimistic: 226.55


Eli Lilly and Comp. stock forecast for Dec 2021.
Estimated Average Forecasted Eli Lilly and Comp. Price: 209.21. Negative monthly dynamics of the instrument is expected with 17.705% volatility is expected.

Pessimistic forecast: 189.63

Optimistic: 230.43



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 110.33 (18.06.2021) -1.16 %
AbbVie Inc.
ABBV 113.12 (18.06.2021) -1.55 %
Aeterna Zentaris Inc.
AEZS 0.9049 (17.06.2021) -4.09 %
Allakos Inc.
ALLK 89.38 (17.06.2021) 0.13 %
Allogene Therapeutics, Inc.
ALLO 24.69 (17.06.2021) -2.33 %
Amgen Inc.
AMGN 238.68 (18.06.2021) -0.86 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.36 (17.06.2021) 0.00 %
Aurora Cannabis Inc.
ACB 9.04 (17.06.2021) -2.38 %
Becton Dickinson and Company
BDX 240.25 (17.06.2021) -0.01 %
Biogen Inc.
BIIB 388.44 (18.06.2021) 1.28 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 94.99 (18.06.2021) 0.76 %
BioNTech SE
BNTX 212.42 (18.06.2021) -0.83 %
bluebird bio, Inc.
BLUE 32.98 (17.06.2021) 0.61 %
Boston Scientific Corp.
BSX 43.02 (18.06.2021) -0.76 %
Bristol-Myers Squibb Company
BMY 66.47 (18.06.2021) -0.45 %
Canopy Growth Corp.
CGC 23.91 (17.06.2021) -0.87 %
Castle Biosciences, Inc.
CSTL 73.46 (18.06.2021) -3.47 %
Eli Lilly and Company
LLY 218.55 (18.06.2021) -1.65 %
Emergent BioSolutions Inc.
EBS 60.55 (18.06.2021) -4.07 %
Exelixis, Inc.
EXEL 22.41 (18.06.2021) 1.27 %
G1 Therapeutics, Inc.
GTHX 21.97 (17.06.2021) 1.10 %
Gilead Sciences, Inc.
GILD 67.22 (17.06.2021) -0.16 %
GlaxoSmithKline plc
GSK 40.57 (17.06.2021) -0.22 %
GoodRx Holdings, Inc.
GDRX 37.89 (17.06.2021) 2.02 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 83.96 (18.06.2021) 1.00 %
Inovio Pharmaceuticals, Inc.
INO 8.49 (18.06.2021) -3.74 %
Johnson & Johnson
JNJ 161.98 (18.06.2021) -1.96 %
Medtronic plc.
MDT 123.23 (18.06.2021) -1.58 %
Merck & Co., Inc.
MRK 76.61 (18.06.2021) -0.80 %
Moderna, Inc.
MRNA 202.47 (17.06.2021) 2.34 %
Novartis AG
NVS 94.15 (17.06.2021) 0.38 %
Novavax, Inc.
NVAX 179.89 (17.06.2021) 2.07 %
ObsEva SA
OBSV 2.97 (17.06.2021) -0.67 %
OrganiGram Holdings Inc.
OGI 2.91 (18.06.2021) -4.28 %
Pfizer Inc.
PFE 38.81 (18.06.2021) -1.70 %
Regeneron Pharmaceuticals, Inc.
REGN 537.92 (18.06.2021) 0.36 %
Sanofi
SNY 53.24 (17.06.2021) -0.34 %
Schrodinger, Inc.
SDGR 74.01 (18.06.2021) -2.72 %
Senseonics Holdings, Inc.
SENS 3.62 (17.06.2021) -1.09 %
Sorrento Therapeutics, Inc.
SRNE 8.67 (17.06.2021) -0.34 %
Stryker Corp.
SYK 254.91 (18.06.2021) -1.79 %
Sundial Growers Inc.
SNDL 0.923 (18.06.2021) -3.85 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 10.12 (18.06.2021) -2.69 %
Thermo Fisher Scientific Inc.
TMO 482.47 (18.06.2021) -0.74 %
Tilray, Inc.
TLRY 16.91 (18.06.2021) -3.21 %
UnitedHealth Group, Inc.
UNH 389.37 (18.06.2021) -2.01 %
Veeva Systems Inc.
VEEV 306.7 (18.06.2021) 0.44 %
Zomedica Corp.
ZOM 0.9035 (17.06.2021) 0.74 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.47 (18.06.2021) -1.97 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.